MedDataX Logo

Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric

NCT ID: NCT02907580

Last Updated: 2017-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-13

Study Completion Date

2017-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate parents and patients, public health entities and physicians give informational handouts in various forms. However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. Few, if any, studies have analyzed the relationship between influenza vaccine attitudes and intention with actual vaccine receipt in the pediatric population. These results will help to understand the relationship between parent's vaccine perception and the intent to vaccinate versus the child's receipt of the influenza vaccine, as well as to optimize educational information given to families regarding the influenza vaccine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influenza Vaccine Randomized Educational Trial: Adult

NCT02907645

Vaccination Influenza
COMPLETED NA

Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine

NCT02909855

Influenza Vaccine, Influenza
COMPLETED

Pilot Text Message for Influenza Vaccination

NCT01761734

Influenza
COMPLETED NA

Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging

NCT02295007

Fever Wheezing
COMPLETED NA

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

NCT01146912

Influenza
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccination Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Local educational data

Local-based educational handout

Group Type EXPERIMENTAL

Local educational information

Intervention Type BEHAVIORAL

Participants in this arm receive educational information regarding influenza vaccination based on local educational information.

National educational data

National-based educational handout

Group Type EXPERIMENTAL

National educational information

Intervention Type BEHAVIORAL

Participants in this arm receive educational information regarding influenza vaccination based on national educational information.

Usual care

No educational information other than provided as usual care by health care providers

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Local educational information

Participants in this arm receive educational information regarding influenza vaccination based on local educational information.

Intervention Type BEHAVIORAL

National educational information

Participants in this arm receive educational information regarding influenza vaccination based on national educational information.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age at least 6 months

Exclusion Criteria

* Receipt of influenza vaccination that season
Minimum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Columbia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Melissa Stockwell

Associate Professor of Pediatrics and Population and Family Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melissa Stockwell, MD MPH

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Columbia University Medical Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Scott VP, Opel DJ, Reifler J, Rikin S, Pethe K, Barrett A, Stockwell MS. Office-Based Educational Handout for Influenza Vaccination: A Randomized Controlled Trial. Pediatrics. 2019 Aug;144(2):e20182580. doi: 10.1542/peds.2018-2580. Epub 2019 Jul 10.

Reference Type DERIVED
PMID: 31292219 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAAQ9636

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Collaborative Efforts to Increase Flu Vaccination
NCT01403649 COMPLETED NA
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
NCT03287830 COMPLETED NA
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
NCT02358083 COMPLETED NA
Influenza Reminder Text-Messaging
NCT06587984 COMPLETED NA
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 COMPLETED
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 COMPLETED PHASE4
Adult Influenza Vaccination Text Message Reminders
NCT01942824 COMPLETED NA
Impact of Influenza Vaccination in Pregnancy Video Education
NCT02151201 COMPLETED NA
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934 COMPLETED
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
NCT00570037 COMPLETED NA
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
NCT01764269 COMPLETED NA
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515 COMPLETED NA
Vaccine Chatbot for Improving Influenza Vaccination Uptake
NCT06657573 NOT_YET_RECRUITING NA
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
NCT01662583 COMPLETED NA
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York State
NCT02924467 COMPLETED NA
Development of Childhood Anti-Influenza Immunity
NCT03673345 COMPLETED PHASE4
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 COMPLETED PHASE1/PHASE2
Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting
NCT04568785 COMPLETED NA
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 COMPLETED NA
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates
NCT02761551 COMPLETED NA
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
NCT00976820 COMPLETED PHASE2
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 COMPLETED NA
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
NCT00812110 COMPLETED PHASE4
Combining Entertainment & Influenza Education for Pediatric Patients
NCT01788514 COMPLETED NA
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
NCT00644540 COMPLETED PHASE2